Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes
Authors:
- Mehdi KarouiMKMehdi Karoui
- Luca ViganoLVLuca Vigano
- Michael KlugerMKMichael Kluger
- Alain LucianiALAlain Luciani
- Alexis LaurentALAlexis Laurent
- Daniel AzoulayDADaniel Azoulay
- Daniel CherquiDCDaniel Cherqui
- 1 February 2013
- journal article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (1) , 47-55
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial TreatmentJournal of Clinical Oncology, 2009
- Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastasesBMC Cancer, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasesBritish Journal of Surgery, 2007
- Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?Journal of Clinical Oncology, 2006
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liverBritish Journal of Surgery, 2003